img

Global Daptomycin API Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Daptomycin API Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Daptomycin API in this report.
Daptomycin API report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Daptomycin API market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from 350mg/vial and 500mg/vial are the major drivers for the industry.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Daptomycin API market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Xellia Pharmaceuticals
Rochem International Inc
Tecoland Corporation
Livzon Group Fuzhou Fuxing Pharmaceutical Co
Chongqing DaXin Pharmaceutical Co
Suzhou Pharmaceutical Technology Co
Huazhong Pharmaceutical Co
Athos
Segment by Type
99%
98%
Others

Segment by Application


350mg/vial
500mg/vial
Others

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Daptomycin API market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Daptomycin API, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Daptomycin API industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Daptomycin API in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Daptomycin API introduction, etc. Daptomycin API Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Daptomycin API market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Daptomycin API Market Overview
1.1 Daptomycin API Product Overview
1.2 Daptomycin API Market Segment by Type
1.2.1 99%
1.2.2 98%
1.2.3 Others
1.3 Global Daptomycin API Market Size by Type
1.3.1 Global Daptomycin API Market Size Overview by Type (2018-2029)
1.3.2 Global Daptomycin API Historic Market Size Review by Type (2018-2024)
1.3.3 Global Daptomycin API Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Daptomycin API Sales Breakdown by Type (2018-2024)
1.4.2 Europe Daptomycin API Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Daptomycin API Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Daptomycin API Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Daptomycin API Sales Breakdown by Type (2018-2024)
2 Global Daptomycin API Market Competition by Company
2.1 Global Top Players by Daptomycin API Sales (2018-2024)
2.2 Global Top Players by Daptomycin API Revenue (2018-2024)
2.3 Global Top Players by Daptomycin API Price (2018-2024)
2.4 Global Top Manufacturers Daptomycin API Manufacturing Base Distribution, Sales Area, Product Type
2.5 Daptomycin API Market Competitive Situation and Trends
2.5.1 Daptomycin API Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Daptomycin API Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Daptomycin API as of 2022)
2.7 Date of Key Manufacturers Enter into Daptomycin API Market
2.8 Key Manufacturers Daptomycin API Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Daptomycin API Status and Outlook by Region
3.1 Global Daptomycin API Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Daptomycin API Historic Market Size by Region
3.2.1 Global Daptomycin API Sales in Volume by Region (2018-2024)
3.2.2 Global Daptomycin API Sales in Value by Region (2018-2024)
3.2.3 Global Daptomycin API Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Daptomycin API Forecasted Market Size by Region
3.3.1 Global Daptomycin API Sales in Volume by Region (2024-2029)
3.3.2 Global Daptomycin API Sales in Value by Region (2024-2029)
3.3.3 Global Daptomycin API Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Daptomycin API by Application
4.1 Daptomycin API Market Segment by Application
4.1.1 350mg/vial
4.1.2 500mg/vial
4.1.3 Others
4.2 Global Daptomycin API Market Size by Application
4.2.1 Global Daptomycin API Market Size Overview by Application (2018-2029)
4.2.2 Global Daptomycin API Historic Market Size Review by Application (2018-2024)
4.2.3 Global Daptomycin API Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Daptomycin API Sales Breakdown by Application (2018-2024)
4.3.2 Europe Daptomycin API Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Daptomycin API Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Daptomycin API Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Daptomycin API Sales Breakdown by Application (2018-2024)
5 North America Daptomycin API by Country
5.1 North America Daptomycin API Historic Market Size by Country
5.1.1 North America Daptomycin API Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Daptomycin API Sales in Volume by Country (2018-2024)
5.1.3 North America Daptomycin API Sales in Value by Country (2018-2024)
5.2 North America Daptomycin API Forecasted Market Size by Country
5.2.1 North America Daptomycin API Sales in Volume by Country (2024-2029)
5.2.2 North America Daptomycin API Sales in Value by Country (2024-2029)
6 Europe Daptomycin API by Country
6.1 Europe Daptomycin API Historic Market Size by Country
6.1.1 Europe Daptomycin API Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Daptomycin API Sales in Volume by Country (2018-2024)
6.1.3 Europe Daptomycin API Sales in Value by Country (2018-2024)
6.2 Europe Daptomycin API Forecasted Market Size by Country
6.2.1 Europe Daptomycin API Sales in Volume by Country (2024-2029)
6.2.2 Europe Daptomycin API Sales in Value by Country (2024-2029)
7 Asia-Pacific Daptomycin API by Region
7.1 Asia-Pacific Daptomycin API Historic Market Size by Region
7.1.1 Asia-Pacific Daptomycin API Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Daptomycin API Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Daptomycin API Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Daptomycin API Forecasted Market Size by Region
7.2.1 Asia-Pacific Daptomycin API Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Daptomycin API Sales in Value by Region (2024-2029)
8 Latin America Daptomycin API by Country
8.1 Latin America Daptomycin API Historic Market Size by Country
8.1.1 Latin America Daptomycin API Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Daptomycin API Sales in Volume by Country (2018-2024)
8.1.3 Latin America Daptomycin API Sales in Value by Country (2018-2024)
8.2 Latin America Daptomycin API Forecasted Market Size by Country
8.2.1 Latin America Daptomycin API Sales in Volume by Country (2024-2029)
8.2.2 Latin America Daptomycin API Sales in Value by Country (2024-2029)
9 Middle East and Africa Daptomycin API by Country
9.1 Middle East and Africa Daptomycin API Historic Market Size by Country
9.1.1 Middle East and Africa Daptomycin API Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Daptomycin API Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Daptomycin API Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Daptomycin API Forecasted Market Size by Country
9.2.1 Middle East and Africa Daptomycin API Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Daptomycin API Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Xellia Pharmaceuticals
10.1.1 Xellia Pharmaceuticals Company Information
10.1.2 Xellia Pharmaceuticals Introduction and Business Overview
10.1.3 Xellia Pharmaceuticals Daptomycin API Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Xellia Pharmaceuticals Daptomycin API Products Offered
10.1.5 Xellia Pharmaceuticals Recent Development
10.2 Rochem International Inc
10.2.1 Rochem International Inc Company Information
10.2.2 Rochem International Inc Introduction and Business Overview
10.2.3 Rochem International Inc Daptomycin API Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Rochem International Inc Daptomycin API Products Offered
10.2.5 Rochem International Inc Recent Development
10.3 Tecoland Corporation
10.3.1 Tecoland Corporation Company Information
10.3.2 Tecoland Corporation Introduction and Business Overview
10.3.3 Tecoland Corporation Daptomycin API Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Tecoland Corporation Daptomycin API Products Offered
10.3.5 Tecoland Corporation Recent Development
10.4 Livzon Group Fuzhou Fuxing Pharmaceutical Co
10.4.1 Livzon Group Fuzhou Fuxing Pharmaceutical Co Company Information
10.4.2 Livzon Group Fuzhou Fuxing Pharmaceutical Co Introduction and Business Overview
10.4.3 Livzon Group Fuzhou Fuxing Pharmaceutical Co Daptomycin API Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Livzon Group Fuzhou Fuxing Pharmaceutical Co Daptomycin API Products Offered
10.4.5 Livzon Group Fuzhou Fuxing Pharmaceutical Co Recent Development
10.5 Chongqing DaXin Pharmaceutical Co
10.5.1 Chongqing DaXin Pharmaceutical Co Company Information
10.5.2 Chongqing DaXin Pharmaceutical Co Introduction and Business Overview
10.5.3 Chongqing DaXin Pharmaceutical Co Daptomycin API Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Chongqing DaXin Pharmaceutical Co Daptomycin API Products Offered
10.5.5 Chongqing DaXin Pharmaceutical Co Recent Development
10.6 Suzhou Pharmaceutical Technology Co
10.6.1 Suzhou Pharmaceutical Technology Co Company Information
10.6.2 Suzhou Pharmaceutical Technology Co Introduction and Business Overview
10.6.3 Suzhou Pharmaceutical Technology Co Daptomycin API Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Suzhou Pharmaceutical Technology Co Daptomycin API Products Offered
10.6.5 Suzhou Pharmaceutical Technology Co Recent Development
10.7 Huazhong Pharmaceutical Co
10.7.1 Huazhong Pharmaceutical Co Company Information
10.7.2 Huazhong Pharmaceutical Co Introduction and Business Overview
10.7.3 Huazhong Pharmaceutical Co Daptomycin API Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Huazhong Pharmaceutical Co Daptomycin API Products Offered
10.7.5 Huazhong Pharmaceutical Co Recent Development
10.8 Athos
10.8.1 Athos Company Information
10.8.2 Athos Introduction and Business Overview
10.8.3 Athos Daptomycin API Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Athos Daptomycin API Products Offered
10.8.5 Athos Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Daptomycin API Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Daptomycin API Industrial Chain Analysis
11.4 Daptomycin API Market Dynamics
11.4.1 Daptomycin API Industry Trends
11.4.2 Daptomycin API Market Drivers
11.4.3 Daptomycin API Market Challenges
11.4.4 Daptomycin API Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Daptomycin API Distributors
12.3 Daptomycin API Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of 99%
Table 2. Major Company of 98%
Table 3. Major Company of Others
Table 4. Global Daptomycin API Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Daptomycin API Sales by Type (2018-2024) & (MT)
Table 6. Global Daptomycin API Sales Market Share in Volume by Type (2018-2024)
Table 7. Global Daptomycin API Sales by Type (2018-2024) & (US& Million)
Table 8. Global Daptomycin API Market Share in Value by Type (2018-2024)
Table 9. Global Daptomycin API Price by Type (2018-2024) & (USD/MT)
Table 10. Global Daptomycin API Sales by Type (2024-2029) & (MT)
Table 11. Global Daptomycin API Sales Market Share in Volume by Type (2024-2029)
Table 12. Global Daptomycin API Sales by Type (2024-2029) & (US$ Million)
Table 13. Global Daptomycin API Sales Market Share in Value by Type (2024-2029)
Table 14. Global Daptomycin API Price by Type (2024-2029) & (USD/MT)
Table 15. North America Daptomycin API Sales by Type (2018-2024) & (MT)
Table 16. North America Daptomycin API Sales by Type (2018-2024) & (US$ Million)
Table 17. Europe Daptomycin API Sales (MT) by Type (2018-2024)
Table 18. Europe Daptomycin API Sales by Type (2018-2024) & (US$ Million)
Table 19. Asia-Pacific Daptomycin API Sales (MT) by Type (2018-2024)
Table 20. Asia-Pacific Daptomycin API Sales by Type (2018-2024) & (US$ Million)
Table 21. Latin America Daptomycin API Sales (MT) by Type (2018-2024)
Table 22. Latin America Daptomycin API Sales by Type (2018-2024) & (US$ Million)
Table 23. Middle East and Africa Daptomycin API Sales (MT) by Type (2018-2024)
Table 24. Middle East and Africa Daptomycin API Sales by Type (2018-2024) & (US$ Million)
Table 25. Global Daptomycin API Sales by Company (2018-2024) & (MT)
Table 26. Global Daptomycin API Sales Share by Company (2018-2024)
Table 27. Global Daptomycin API Revenue by Company (2018-2024) & (US$ Million)
Table 28. Global Daptomycin API Revenue Share by Company (2018-2024)
Table 29. Global Market Daptomycin API Price by Company (2018-2024) & (USD/MT)
Table 30. Global Daptomycin API Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Daptomycin API Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Daptomycin API as of 2022)
Table 33. Date of Key Manufacturers Enter into Daptomycin API Market
Table 34. Key Manufacturers Daptomycin API Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Daptomycin API Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 37. Global Daptomycin API Sales by Region (2018-2024) & (MT)
Table 38. Global Daptomycin API Sales Market Share in Volume by Region (2018-2024)
Table 39. Global Daptomycin API Sales by Region (2018-2024) & (US$ Million)
Table 40. Global Daptomycin API Sales Market Share in Value by Region (2018-2024)
Table 41. Global Daptomycin API Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 42. Global Daptomycin API Sales by Region (2024-2029) & (MT)
Table 43. Global Daptomycin API Sales Market Share in Volume by Region (2024-2029)
Table 44. Global Daptomycin API Sales by Region (2024-2029) & (US$ Million)
Table 45. Global Daptomycin API Sales Market Share in Value by Region (2024-2029)
Table 46. Global Daptomycin API Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2024-2029)
Table 47. Global Daptomycin API Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 48. Global Daptomycin API Sales by Application (2018-2024) & (MT)
Table 49. Global Daptomycin API Sales Market Share in Volume by Application (2018-2024)
Table 50. Global Daptomycin API Sales by Application (2018-2024) & (US$ Million)
Table 51. Global Daptomycin API Sales Market Share in Value by Application (2018-2024)
Table 52. Global Daptomycin API Price by Application (2018-2024) & (USD/MT)
Table 53. Global Daptomycin API Sales by Application (2024-2029) & (MT)
Table 54. Global Daptomycin API Sales Market Share in Volume by Application (2024-2029)
Table 55. Global Daptomycin API Sales by Application (2024-2029) & (US$ Million)
Table 56. Global Daptomycin API Sales Market Share in Value by Application (2024-2029)
Table 57. Global Daptomycin API Price by Application (2024-2029) & (USD/MT)
Table 58. North America Daptomycin API Sales by Application (2018-2024) (MT)
Table 59. North America Daptomycin API Sales by Application (2018-2024) & (US$ Million)
Table 60. Europe Daptomycin API Sales by Application (2018-2024) (MT)
Table 61. Europe Daptomycin API Sales by Application (2018-2024) & (US$ Million)
Table 62. Asia-Pacific Daptomycin API Sales by Application (2018-2024) (MT)
Table 63. Asia-Pacific Daptomycin API Sales by Application (2018-2024) & (US$ Million)
Table 64. Latin America Daptomycin API Sales by Application (2018-2024) (MT)
Table 65. Latin America Daptomycin API Sales by Application (2018-2024) & (US$ Million)
Table 66. Middle East and Africa Daptomycin API Sales by Application (2018-2024) (MT)
Table 67. Middle East and Africa Daptomycin API Sales by Application (2018-2024) & (US$ Million)
Table 68. North America Daptomycin API Sales by Country (2018-2024) & (MT)
Table 69. North America Daptomycin API Sales Market Share in Volume by Country (2018-2024)
Table 70. North America Daptomycin API Sales by Country (2018-2024) & (US$ Million)
Table 71. North America Daptomycin API Sales Market Share in Value by Country (2018-2024)
Table 72. North America Daptomycin API Sales by Country (2024-2029) & (MT)
Table 73. North America Daptomycin API Sales Market Share in Volume by Country (2024-2029)
Table 74. North America Daptomycin API Sales by Country (2024-2029) & (US$ Million)
Table 75. North America Daptomycin API Sales Market Share in Value by Country (2024-2029)
Table 76. Europe Daptomycin API Sales by Country (2018-2024) & (MT)
Table 77. Europe Daptomycin API Sales Market Share in Volume by Country (2018-2024)
Table 78. Europe Daptomycin API Sales by Country (2018-2024) & (US$ Million)
Table 79. Europe Daptomycin API Sales Market Share in Value by Country (2018-2024)
Table 80. Europe Daptomycin API Sales by Country (2024-2029) & (MT)
Table 81. Europe Daptomycin API Sales Market Share in Volume by Country (2024-2029)
Table 82. Europe Daptomycin API Sales by Country (2024-2029) & (US$ Million)
Table 83. Europe Daptomycin API Sales Market Share in Value by Country (2024-2029)
Table 84. Asia-Pacific Daptomycin API Sales by Region (2018-2024) & (MT)
Table 85. Asia-Pacific Daptomycin API Sales Market Share in Volume by Region (2018-2024)
Table 86. Asia-Pacific Daptomycin API Sales by Region (2018-2024) & (US$ Million)
Table 87. Asia-Pacific Daptomycin API Sales Market Share in Value by Region (2018-2024)
Table 88. Asia-Pacific Daptomycin API Sales by Region (2024-2029) & (MT)
Table 89. Asia-Pacific Daptomycin API Sales Market Share in Volume by Region (2024-2029)
Table 90. Asia-Pacific Daptomycin API Sales by Region (2024-2029) & (US$ Million)
Table 91. Asia-Pacific Daptomycin API Sales Market Share in Value by Region (2024-2029)
Table 92. Latin America Daptomycin API Sales by Country (2018-2024) & (MT)
Table 93. Latin America Daptomycin API Sales Market Share in Volume by Country (2018-2024)
Table 94. Latin America Daptomycin API Sales by Country (2018-2024) & (US$ Million)
Table 95. Latin America Daptomycin API Sales Market Share in Value by Country (2018-2024)
Table 96. Latin America Daptomycin API Sales by Country (2024-2029) & (MT)
Table 97. Latin America Daptomycin API Sales Market Share in Volume by Country (2024-2029)
Table 98. Latin America Daptomycin API Sales by Country (2024-2029) & (US$ Million)
Table 99. Latin America Daptomycin API Sales Market Share in Value by Country (2024-2029)
Table 100. Middle East and Africa Daptomycin API Sales by Country (2018-2024) & (MT)
Table 101. Middle East and Africa Daptomycin API Sales Market Share in Volume by Country (2018-2024)
Table 102. Middle East and Africa Daptomycin API Sales by Country (2018-2024) & (US$ Million)
Table 103. Middle East and Africa Daptomycin API Sales Market Share in Value by Country (2018-2024)
Table 104. Middle East and Africa Daptomycin API Sales by Country (2024-2029) & (MT)
Table 105. Middle East and Africa Daptomycin API Sales Market Share in Volume by Country (2024-2029)
Table 106. Middle East and Africa Daptomycin API Sales by Country (2024-2029) & (US$ Million)
Table 107. Middle East and Africa Daptomycin API Sales Market Share in Value by Country (2024-2029)
Table 108. Xellia Pharmaceuticals Company Information
Table 109. Xellia Pharmaceuticals Introduction and Business Overview
Table 110. Xellia Pharmaceuticals Daptomycin API Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 111. Xellia Pharmaceuticals Daptomycin API Product
Table 112. Xellia Pharmaceuticals Recent Development
Table 113. Rochem International Inc Company Information
Table 114. Rochem International Inc Introduction and Business Overview
Table 115. Rochem International Inc Daptomycin API Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 116. Rochem International Inc Daptomycin API Product
Table 117. Rochem International Inc Recent Development
Table 118. Tecoland Corporation Company Information
Table 119. Tecoland Corporation Introduction and Business Overview
Table 120. Tecoland Corporation Daptomycin API Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 121. Tecoland Corporation Daptomycin API Product
Table 122. Tecoland Corporation Recent Development
Table 123. Livzon Group Fuzhou Fuxing Pharmaceutical Co Company Information
Table 124. Livzon Group Fuzhou Fuxing Pharmaceutical Co Introduction and Business Overview
Table 125. Livzon Group Fuzhou Fuxing Pharmaceutical Co Daptomycin API Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 126. Livzon Group Fuzhou Fuxing Pharmaceutical Co Daptomycin API Product
Table 127. Livzon Group Fuzhou Fuxing Pharmaceutical Co Recent Development
Table 128. Chongqing DaXin Pharmaceutical Co Company Information
Table 129. Chongqing DaXin Pharmaceutical Co Introduction and Business Overview
Table 130. Chongqing DaXin Pharmaceutical Co Daptomycin API Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 131. Chongqing DaXin Pharmaceutical Co Daptomycin API Product
Table 132. Chongqing DaXin Pharmaceutical Co Recent Development
Table 133. Suzhou Pharmaceutical Technology Co Company Information
Table 134. Suzhou Pharmaceutical Technology Co Introduction and Business Overview
Table 135. Suzhou Pharmaceutical Technology Co Daptomycin API Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 136. Suzhou Pharmaceutical Technology Co Daptomycin API Product
Table 137. Suzhou Pharmaceutical Technology Co Recent Development
Table 138. Huazhong Pharmaceutical Co Company Information
Table 139. Huazhong Pharmaceutical Co Introduction and Business Overview
Table 140. Huazhong Pharmaceutical Co Daptomycin API Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 141. Huazhong Pharmaceutical Co Daptomycin API Product
Table 142. Huazhong Pharmaceutical Co Recent Development
Table 143. Athos Company Information
Table 144. Athos Introduction and Business Overview
Table 145. Athos Daptomycin API Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 146. Athos Daptomycin API Product
Table 147. Athos Recent Development
Table 148. Key Raw Materials Lists
Table 149. Raw Materials Key Suppliers Lists
Table 150. Daptomycin API Market Trends
Table 151. Daptomycin API Market Drivers
Table 152. Daptomycin API Market Challenges
Table 153. Daptomycin API Market Restraints
Table 154. Daptomycin API Distributors List
Table 155. Daptomycin API Downstream Customers
Table 156. Research Programs/Design for This Report
Table 157. Key Data Information from Secondary Sources
Table 158. Key Data Information from Primary Sources
List of Figures
Figure 1. Daptomycin API Product Picture
Figure 2. Global Daptomycin API Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Daptomycin API Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Daptomycin API Sales Status and Outlook (2018-2029) & (MT)
Figure 5. Product Picture of 99%
Figure 6. Global 99% Sales YoY Growth (2018-2029) & (MT)
Figure 7. Product Picture of 98%
Figure 8. Global 98% Sales YoY Growth (2018-2029) & (MT)
Figure 9. Product Picture of Others
Figure 10. Global Others Sales YoY Growth (2018-2029) & (MT)
Figure 11. Global Daptomycin API Sales by Type (2018-2029) & (US$ Million)
Figure 12. Global Daptomycin API Sales Market Share by Type in 2022 & 2029
Figure 13. North America Daptomycin API Sales Market Share in Volume by Type in 2022
Figure 14. North America Daptomycin API Sales Market Share in Value by Type in 2022
Figure 15. Europe Daptomycin API Sales Market Share in Volume by Type in 2022
Figure 16. Europe Daptomycin API Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific Daptomycin API Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific Daptomycin API Sales Market Share in Value by Type in 2022
Figure 19. Latin America Daptomycin API Sales Market Share in Volume by Type in 2022
Figure 20. Latin America Daptomycin API Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa Daptomycin API Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa Daptomycin API Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Daptomycin API Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Daptomycin API Revenue in 2022
Figure 25. Daptomycin API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 26. Product Picture of 350mg/vial
Figure 27. Global 350mg/vial Sales YoY Growth (2018-2029) & (MT)
Figure 28. Product Picture of 500mg/vial
Figure 29. Global 500mg/vial Sales YoY Growth (2018-2029) & (MT)
Figure 30. Product Picture of Others
Figure 31. Global Others Sales YoY Growth (2018-2029) & (MT)
Figure 32. Global Daptomycin API Sales by Application (2018-2029) & (US$ Million)
Figure 33. Global Daptomycin API Sales Market Share by Application in 2022 & 2029
Figure 34. North America Daptomycin API Sales Market Share in Volume by Application in 2022
Figure 35. North America Daptomycin API Sales Market Share in Value by Application in 2022
Figure 36. Europe Daptomycin API Sales Market Share in Volume by Application in 2022
Figure 37. Europe Daptomycin API Sales Market Share in Value by Application in 2022
Figure 38. Asia-Pacific Daptomycin API Sales Market Share in Volume by Application in 2022
Figure 39. Asia-Pacific Daptomycin API Sales Market Share in Value by Application in 2022
Figure 40. Latin America Daptomycin API Sales Market Share in Volume by Application in 2022
Figure 41. Latin America Daptomycin API Sales Market Share in Value by Application in 2022
Figure 42. Middle East and Africa Daptomycin API Sales Market Share in Value by Application in 2022
Figure 43. Key Raw Materials Price
Figure 44. Daptomycin API Manufacturing Cost Structure
Figure 45. Daptomycin API Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed